Ubs Oconnor LLC Insmed Inc Transaction History

Ubs Oconnor LLC

$1.51 Billion
Q4 2024

A detailed history of Ubs Oconnor LLC transactions in Insmed Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 26,615 shares of INSM stock, worth $1.99 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

26,615

Holding current value

$1.99 Million

% of portfolio

0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $317,926 - $367,517	4,796 Added 21.98%	26,615 $1.84 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $474,300 - $604,426	7,650 Added 53.99%	21,819 $1.59 Million
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $865,436 - $2.74 Million	-39,338 Reduced 73.52%	14,169 $949,000
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $82,818 - $96,406	-3,220 Reduced 5.68%	53,507 $1.45 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $60,072 - $81,413	-2,565 Reduced 4.33%	56,727 $1.76 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $1.05 Million - $1.43 Million	-53,000 Reduced 47.2%	59,292 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $1.85 Million - $2.37 Million	112,292 New	112,292 $2.37 Billion
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $578,660 - $773,327	35,588 Added 20.25%	211,340 $3.6 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $1 Million - $1.36 Million	58,908 Added 50.42%	175,752 $0
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $668,160 - $902,720	-32,000 Reduced 21.5%	116,844 $2.52 Billion
Q2 2022 Aug 12, 2022	BUY	$17.07 - $25.71 $1.26 Million - $1.9 Million	73,844 Added 98.46%	148,844 $2.94 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $714,700 - $984,550	35,000 Added 87.5%	75,000 $1.76 Million
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $985,734 - $1.38 Million	-42,858 Reduced 51.72%	40,000 $0
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $961,981 - $2.59 Million	82,858	82,858 $0

Others Institutions Holding INSM

# of Institutions

498

Shares Held

189M

Call Options Held

3.21M

Put Options Held

2.72M

Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$1.36 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$1.07 Billion
0.02% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

13M
Shares

$971 Million
84.75% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.7M
Shares

$951 Million
0.1% of portfolio
Capital International Investors Los Angeles, CA

7.12M
Shares

$533 Million
0.1% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.1B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account